The European DNA Vaccine market is anticipated to grow at a CAGR 42.3% during the forecast period. European Union is one of the unique economic and political unions between countries that together cover much of the continent. As per the International Monetary Fund, the GDP of the European Union was $19.6 trillion in 2017. As per World Bank, per capita GDP of the European Union was $39,000 in 2015with a growth of 5.5% compared to 2014. The major countries which are contributing to the DNA vaccination market are the UK, Germany, France, Italy, and Spain. The growth of the European region is backed by a significant investment on DNA vaccination by the countries.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/european-dna-vaccines-market
The UK is estimated to be the dominating region in the European DNA vaccine market. Furthermore, it is also the fastest-growing region in the DNA vaccine market owing to the collaboration of the companies with Cancer Research UK for the development of a vaccine against oncology. In addition, research institutes in the country are raising funds for the development of DNA-based vaccines. Germany is estimated to be the second-largest market in the European DNA vaccine market. The government organization is much concerned about the vaccination hence due to this the coverage area of most of the countries is more than 90% for most of the diseases. Each country has its own vaccination schedule as per their environment and other factors. The UK is a major contributor in the European market.
The key market players that are active in the market include GE Healthcare, GlaxoSmithKline PLC., Merck & Co., Pfizer Inc., Sanofi Inc., Roche Diagnostics GMBH, Xenetic Biosciences Inc., Eli Lilly and Co., Novartis AG and Inovio Pharmaceuticals Inc. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.
A full report of European DNA Vaccine Market available @ https://www.omrglobal.com/industry-reports/european-dna-vaccines-market
European DNA Vaccine Market Segmentation
By Type
- Animal DNA Vaccine
- Human DNA Vaccine
By Technology
- Plasmid DNA Vaccine
- Plasmid DNA Delivery
By Application
- Oncology
- Infectious Disease
- Others
Regional Analysis
- European
- United Kingdom
- Germany
- France
- Italy
- Spain
- Rest of European
Company Profiles
- Eli Lilly and Co.
- GE Healthcare
- Glaxosmithkline PLC.
- Inovio Pharmaceuticals Inc.
- Merck & Co.
- Novartis AG
- Pfizer Inc.
- Roche Diagnostics GMBH
- Sanofi Inc.
- Xenetic Biosciences Inc.
